Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
External and Internal Respiration01:24

External and Internal Respiration

6.9K
External respiration occurs in the lungs, and it is the first step in the journey of oxygen inside the body. When we inhale, oxygen enters our lungs and diffuses across the thin alveolar membrane. The alveoli are tiny, air-filled sacs that provide a vast surface area for gas exchange. Oxygen in the alveoli has a higher partial pressure (105 mmHg) than in the adjacent pulmonary capillaries (40 mmHg), establishing a pressure gradient. As a result, oxygen molecules move from the alveoli into the...
6.9K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K
Pulmonary Function Tests01:25

Pulmonary Function Tests

718
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
718

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seasonality and environmental determinants of exhaled nitric oxide in individuals with and without chronic respiratory diseases.

Environmental epidemiology (Philadelphia, Pa.)·2026
Same author

Air pollution and cause-specific mortality in EU: a review integrating meta-analysis and meta-regression.

Scientific reports·2026
Same author

Pulmonary Embolism in Patients with Lung Cancer: Incidence and Performance of Prognostic Markers.

Cancers·2026
Same author

Obesity, Air Pollution, and Epigenetic Modifications as Risk Factors for Asthma Phenotypes.

International journal of molecular sciences·2026
Same author

Diagnosis and management of interstitial lung disease with concomitant lung cancer in Italy: Results from the ICARO clinician survey.

Multidisciplinary respiratory medicine·2026
Same author

Artificial intelligence and radiomics in drug-induced interstitial lung disease.

ERJ open research·2026
Same journal

High-Flow Nasal Oxygen in Early Home Pulmonary Rehabilitation for Exertional Hypoxaemia: A Pilot Randomised Feasibility Trial.

Respirology (Carlton, Vic.)·2026
Same journal

Contemporary Concise Review 2025: Asthma.

Respirology (Carlton, Vic.)·2026
Same journal

Early Intervention With Biologics for Asthma Remission: Promising or Premature?

Respirology (Carlton, Vic.)·2026
Same journal

Clinical and Inflammatory Phenotypes During Exacerbations Predict In-Hospital Adverse Outcomes in Asthma-COPD Overlap.

Respirology (Carlton, Vic.)·2026
Same journal

Diagnostic Yield of EBUS Mediastinal Cryobiopsy Versus TBNA in Suspected Lymphoproliferative Disorders: A Prospective Multicentre Study.

Respirology (Carlton, Vic.)·2026
Same journal

Association of Airway Mucus Plugs and Physical Activity, Exercise Tolerance, Sarcopenia, and Frailty in Patients With COPD and Pre-COPD.

Respirology (Carlton, Vic.)·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

11.1K

Small Airways and Pulmonary Diffusing Capacity Decline in an 8-Year Longitudinal Population Study.

Sara Maio1, Anna Angino1, Sandra Baldacci1

  • 1Pulmonary Environmental Epidemiology Unit, CNR Institute of Clinical Physiology, Pisa, Italy.

Respirology (Carlton, Vic.)
|December 4, 2025
PubMed
Summary
This summary is machine-generated.

The single breath nitrogen (SBN2) test

Keywords:
COPDdiffusing capacity of the lung for carbon monoxidelongitudinal studysingle breath nitrogen testsmall airways

More Related Videos

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
08:44

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

1.2K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.6K

Related Experiment Videos

Last Updated: Jan 9, 2026

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

11.1K
Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
08:44

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

1.2K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.6K

Area of Science:

  • Pulmonary Medicine
  • Respiratory Physiology
  • Lung Function Testing

Background:

  • Few longitudinal population studies investigate the link between small airway function (SBN2 test) and diffusing capacity (DLCO).
  • The single breath nitrogen (SBN2) test assesses small airway function.
  • Pulmonary diffusing capacity for carbon monoxide (DLCO) measures gas exchange efficiency.

Purpose of the Study:

  • To determine if the N2-slope from the SBN2 test predicts decline in DLCO and KCO (DLCO/alveolar volume).
  • To assess the relationship between N2-slope, DLCO, and COPD incidence.
  • To evaluate the predictive value of small airway function for COPD development.

Main Methods:

  • Longitudinal observational study with 687 participants followed for 8 years.
  • Baseline SBN2 test, DLCO, and spirometry were performed.
  • Multivariable regression analyses assessed associations between N2-slope, DLCO/KCO decline, and COPD incidence (GOLD and ATS-ERS criteria).

Main Results:

  • The N2-slope significantly predicted declines in DLCO and KCO.
  • Participants with abnormal N2-slope and DLCO showed a substantially higher risk of developing COPD (GOLD and ATS-ERS criteria).
  • COPD incidence was 9.0% (GOLD) and 3.9% (ATS-ERS) over 8 years.

Conclusions:

  • The N2-slope is a valuable predictor of DLCO and KCO decline.
  • Combined abnormal N2-slope and DLCO indicate an increased risk for COPD development.
  • SBN2 test parameters offer insights into future COPD risk.